Table 4 Outcomes
From: Influence of Staphylococcus aureus on Outcomes after Valvular Surgery for Infective Endocarditis
Outcomes | Before PS Matching | After PS Matching | ||||||
|---|---|---|---|---|---|---|---|---|
SA (n = 85) | NSA (n = 238) | OR (95% CI) | p-Value | SA (n = 64) | NSA (n = 64) | OR (95% CI) | p-Value | |
30-day | ||||||||
Composite | 40 (47.1) | 91 (38.2) | 1.44 (0.87–2.37) | 0.160 | 30 (46.9) | 29 (45.3) | 1.06 (0.54–2.10) | 0.860 |
Mortality | 8 (9.4) | 19 (8.0) | 1.20 (0.50–2.85) | 0.680 | 6 (9.4) | 5 (7.8) | 1.20 (0.37–3.93) | 0.760 |
Stroke | 12 (14.3) | 29 (12.2) | 1.20 (0.58–2.48) | 0.620 | 9 (14.1) | 9 (14.1) | 1.00 (0.38–2.66) | 1.000 |
Embolic Events | 18 (21.4) | 34 (14.3) | 1.64 (0.87–3.09) | 0.130 | 13 (20.3) | 11 (17.2) | 1.18 (0.53–2.64) | 0.680 |
Development of ARF | 24 (28.6) | 43 (18.1) | 1.81 (1.02–3.23) | 0.043 | 18 (28.1) | 16 (25.0) | 1.22 (0.51–2.95) | 0.660 |
1 year | ||||||||
Composite | 48 (56.5) | 104 (43.7) | 1.67 (1.01–2.75) | 0.044 | 37 (57.8) | 30 (46.8) | 1.70 (0.78–3.71) | 0.180 |
Mortality | 17 (20.0) | 34 (14.3) | 1.50 (0.79–2.86) | 0.220 | 13 (20.3) | 9 (14.1) | 1.57 (0.61–4.05) | 0.350 |
Stroke | 16 (19.1) | 32 (13.5) | 1.51 (0.78–2.93) | 0.220 | 12 (18.7) | 9 (14.1) | 1.43 (0.54–3.75) | 0.470 |
Embolic Events | 22 (26.2) | 37 (15.6) | 1.93 (1.06–3.51) | 0.032 | 16 (25.0) | 13 (20.3) | 1.27 (0.58–2.80) | 0.550 |
Development of ARF | 28 (33.3) | 51 (21.4) | 1.83 (1.06–3.18) | 0.031 | 22 (34.4) | 18 (28.1) | 1.40 (0.62–3.15) | 0.420 |